U.S. markets closed
  • S&P 500

    4,482.73
    -50.03 (-1.10%)
     
  • Dow 30

    34,715.39
    -313.26 (-0.89%)
     
  • Nasdaq

    14,154.02
    -186.23 (-1.30%)
     
  • Russell 2000

    2,029.12
    -33.67 (-1.63%)
     
  • Crude Oil

    86.29
    -0.67 (-0.77%)
     
  • Gold

    1,838.30
    -4.90 (-0.27%)
     
  • Silver

    24.50
    +0.27 (+1.11%)
     
  • EUR/USD

    1.1308
    -0.0038 (-0.34%)
     
  • 10-Yr Bond

    1.8330
    +0.0060 (+0.33%)
     
  • GBP/USD

    1.3593
    -0.0018 (-0.13%)
     
  • USD/JPY

    114.2000
    -0.1530 (-0.13%)
     
  • BTC-USD

    42,677.09
    +950.34 (+2.28%)
     
  • CMC Crypto 200

    1,014.01
    +18.74 (+1.88%)
     
  • FTSE 100

    7,585.01
    -4.65 (-0.06%)
     
  • Nikkei 225

    27,772.93
    +305.70 (+1.11%)
     

Xenon Reverses Early Gain And Dives Despite Promising Epilepsy Results

·2 min read
Xenon Reverses Early Gain And Dives Despite Promising Epilepsy Results
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • XENE

Xenon Pharmaceuticals highlighted new test results for its epilepsy treatment on Friday. But XENE stock reversed its gains.